Literature DB >> 28436938

Geminin facilitates FoxO3 deacetylation to promote breast cancer cell metastasis.

Lei Zhang1, Meizhen Cai1, Zhicheng Gong1, Bingchang Zhang1, Yuanpei Li1, Li Guan1, Xiaonan Hou1, Qing Li1, Gang Liu2, Zengfu Xue3, Muh-Hua Yang4, Jing Ye5, Y Eugene Chin6, Han You1.   

Abstract

Geminin expression is essential for embryonic development and the maintenance of chromosomal integrity. In spite of this protective role, geminin is also frequently overexpressed in human cancers and the molecular mechanisms underlying its role in tumor progression remain unclear. The histone deacetylase HDAC3 modulates transcription factors to activate or suppress transcription. Little is known about how HDAC3 specifies substrates for modulation among highly homologous transcription factor family members. Here, we have demonstrated that geminin selectively couples the transcription factor forkhead box O3 (FoxO3) to HDAC3, thereby specifically facilitating FoxO3 deacetylation. We determined that geminin-associated HDAC3 deacetylates FoxO3 to block its transcriptional activity, leading to downregulation of the downstream FoxO3 target Dicer, an RNase that suppresses metastasis. Breast cancer cells depleted of geminin or HDAC3 exhibited poor metastatic potential that was attributed to reduced suppression of the FoxO3-Dicer axis. Moreover, elevated levels of geminin, HDAC3, or both together with decreased FoxO3 acetylation and reduced Dicer expression were detected in aggressive human breast cancer specimens. These results underscore a prominent role for geminin in promoting breast cancer metastasis via the enzyme-substrate-coupling mechanism in HDAC3-FoxO3 complex formation.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28436938      PMCID: PMC5451250          DOI: 10.1172/JCI90077

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a.

Authors:  Diego H Castrillon; Lili Miao; Ramya Kollipara; James W Horner; Ronald A DePinho
Journal:  Science       Date:  2003-07-11       Impact factor: 47.728

2.  Regulation of cell cycle progression by forkhead transcription factor FOXO3 through its binding partner DNA replication factor Cdt1.

Authors:  Yiru Zhang; Yuqian Xing; Lei Zhang; Yang Mei; Kazuo Yamamoto; Tak W Mak; Han You
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-26       Impact factor: 11.205

Review 3.  Geminin's double life: chromatin connections that regulate transcription at the transition from proliferation to differentiation.

Authors:  Seongjin Seo; Kristen L Kroll
Journal:  Cell Cycle       Date:  2006-02-15       Impact factor: 4.534

4.  Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state.

Authors:  Dhananjay Yellajoshyula; Ethan S Patterson; Matthew S Elitt; Kristen L Kroll
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-07       Impact factor: 11.205

5.  Expression of the licensing factors, Cdt1 and Geminin, in human colon cancer.

Authors:  V Bravou; H Nishitani; S Y Song; S Taraviras; J Varakis
Journal:  Int J Oncol       Date:  2005-12       Impact factor: 5.650

Review 6.  FOXO transcription factors at the interface between longevity and tumor suppression.

Authors:  Eric L Greer; Anne Brunet
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

7.  Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase.

Authors:  Anne Brunet; Lora B Sweeney; J Fitzhugh Sturgill; Katrin F Chua; Paul L Greer; Yingxi Lin; Hien Tran; Sarah E Ross; Raul Mostoslavsky; Haim Y Cohen; Linda S Hu; Hwei-Ling Cheng; Mark P Jedrychowski; Steven P Gygi; David A Sinclair; Frederick W Alt; Michael E Greenberg
Journal:  Science       Date:  2004-02-19       Impact factor: 47.728

8.  Geminin restrains mesendodermal fate acquisition of embryonic stem cells and is associated with antagonism of Wnt signaling and enhanced polycomb-mediated repression.

Authors:  Elizabeth A Caronna; Ethan S Patterson; Pamela M Hummert; Kristen L Kroll
Journal:  Stem Cells       Date:  2013-08       Impact factor: 6.277

Review 9.  The FoxO code.

Authors:  D R Calnan; A Brunet
Journal:  Oncogene       Date:  2008-04-07       Impact factor: 9.867

10.  Geminin, a neuralizing molecule that demarcates the future neural plate at the onset of gastrulation.

Authors:  K L Kroll; A N Salic; L M Evans; M W Kirschner
Journal:  Development       Date:  1998-08       Impact factor: 6.868

View more
  18 in total

Review 1.  FoxO transcription factors in cancer metabolism.

Authors:  Raj Kumar Yadav; Anoop Singh Chauhan; Li Zhuang; Boyi Gan
Journal:  Semin Cancer Biol       Date:  2018-01-05       Impact factor: 15.707

2.  ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1/FoxO1 activation.

Authors:  Sejeong Shin; Gwen R Buel; Michal J Nagiec; Min-Joon Han; Philippe P Roux; John Blenis; Sang-Oh Yoon
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-06       Impact factor: 11.205

3.  Evaluation of NUF2 and GMNN Expression in Prostate Cancer: Potential Biomarkers for Prostate Cancer Screening.

Authors:  Shaghayegh Pezeshki; Payam Hashemi; Alireza Salimi; Sheida Ebrahimi; Mandana Javanzad; Amir Monfaredan
Journal:  Rep Biochem Mol Biol       Date:  2021-07

4.  GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.

Authors:  Xiaotian Yuan; Ninni Mu; Na Wang; Klas Strååt; Anastasios Sofiadis; Yanxia Guo; Adam Stenman; Kailin Li; Guanghui Cheng; Lu Zhang; Feng Kong; Lars Ekblad; Johan Wennerberg; Inga-Lena Nilsson; C Christofer Juhlin; Catharina Larsson; Dawei Xu
Journal:  Oncogene       Date:  2018-09-04       Impact factor: 9.867

5.  DNA Replication Inhibitor Geminin and Retinoic Acid Signaling Participate in Complex Interactions Associated With Pluripotency.

Authors:  Spyridon Champeris Tsaniras; George J Delinasios; Michalis Petropoulos; Andreas Panagopoulos; Athanasios K Anagnostopoulos; Maria Villiou; Dimitrios Vlachakis; Vasiliki Bravou; Georgios T Stathopoulos; Stavros Taraviras
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 6.  Activating the Anaphase Promoting Complex to Enhance Genomic Stability and Prolong Lifespan.

Authors:  Troy A A Harkness
Journal:  Int J Mol Sci       Date:  2018-06-27       Impact factor: 5.923

7.  Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation.

Authors:  Ye Shen; Kefeng Pu; Kexiao Zheng; Xiaochuan Ma; Jingyi Qin; Li Jiang; Jiong Li
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

8.  Chlorzoxazone, a small molecule drug, augments immunosuppressive capacity of mesenchymal stem cells via modulation of FOXO3 phosphorylation.

Authors:  Luchan Deng; Hongling Li; Xiaodong Su; Yingjie Zhang; Haoying Xu; Linyuan Fan; Junfen Fan; Qin Han; Xueyuan Bai; Robert Chunhua Zhao
Journal:  Cell Death Dis       Date:  2020-03-02       Impact factor: 8.469

9.  MicroRNA-155 increases colon cancer chemoresistance to cisplatin by targeting forkhead box O3.

Authors:  Yuewen Gao; Zhaoyan Liu; Zhaohong Ding; Shicai Hou; Jun Li; Kehua Jiang
Journal:  Oncol Lett       Date:  2018-02-07       Impact factor: 2.967

10.  Insulin-like growth factor 1-induced enolase 2 deacetylation by HDAC3 promotes metastasis of pancreatic cancer.

Authors:  Yan Zheng; Chao Wu; Jimeng Yang; Yue Zhao; Huliang Jia; Min Xue; Da Xu; Feng Yang; Deliang Fu; Chaoqun Wang; Beiyuan Hu; Ze Zhang; Tianen Li; Shican Yan; Xuan Wang; Peter J Nelson; Christiane Bruns; Lunxiu Qin; Qiongzhu Dong
Journal:  Signal Transduct Target Ther       Date:  2020-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.